hereditary ovarian cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.High-risk patients with ovarian cancer; 2.Aged 18–60 years; 3.With an anticipated survival time of =24 months; 4.Capable of independently completing questionnaires, communicating effectively, and cooperating with follow-up procedures; 5.Without definite risk of loss to follow-up (e.g., no plan for long-term residence in other areas, no severe underlying diseases that would preclude follow-up participation); 6.Having received medical treatment or health screening at our hospital and signed the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Patients with a confirmed diagnosis of ovarian cancer (including carcinoma in situ and invasive carcinoma) or other malignant tumors, who are undergoing radiotherapy, chemotherapy, targeted therapy, or immunotherapy; 2.Those with severe organ failure involving the heart, liver, kidneys, lungs, or other vital organs, or in the acute exacerbation stage of severe chronic diseases, and thus unable to tolerate the intervention measures; 3.Those with a history of mental illness, cognitive impairment, or language communication disorders; women who are pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Genetic testing compliance rate;Regular screening completion rate;;Genetic counseling participation rate;First-degree relative screening rate;Preventive surgery implementation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| anxiety and depression levels;self-efficacy; | — |
Countries
China
Contacts
Zhejiang Cancer Hospital